Egalet

Egalet Ltd. is a specialty pharmaceutical company focused on pain management. Based on Egalet technology, the company is developing a series of abuse-deterrent opioids that are about to enter pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies, which controls drug release through the gradual erosion of tablets and optimizes abuse-deterrent properties applicable to a wide range of both opioid and non-opioid medications.